Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
COVID-19
Pharma
EMA suspends AstraZeneca's marketing authorization for COVID vax
The European Medicines Agency has accepted a request from AstraZeneca to withdraw the marketing authorization for its COVID-19 shot Vaxzevria.
Kevin Dunleavy
May 8, 2024 11:33am
BioNTech looks to 2026 for commercial debut in oncology
May 6, 2024 10:44am
Moderna plots launch of its next potential mRNA vaccine approval
May 2, 2024 11:08am
GSK launches mRNA patent infringement case against Pfizer
Apr 26, 2024 10:04am
Pfizer focuses on long COVID in latest 'Dear Scientist' video
Apr 17, 2024 1:10pm
Judge pauses Moderna's infringement case against rival Pfizer
Apr 15, 2024 4:47pm
More News
Novavax investor Shah Capital jabs at vaccine maker
Apr 15, 2024 10:48am
PMCPA chides Pfizer over UK staffer's 2020 Twitter misstep
Mar 29, 2024 9:30am
Invivyd's COVID prophylactic scores FDA emergency nod
Mar 25, 2024 11:59am
COVID vaccine sales come up short again for BioNTech
Mar 20, 2024 11:33am
See more stories